Lipidomics studies on macrophages - RAW 264.7 cells treated with Kdo2-Lipid A and compactin

Introduction | Browse | Search | Download
Mouse-over the above links for more information

Treatment details

LM ID Analyte Treatment Time(hrs) Sample ID Value Units
LMST01010017 Lanosterol cPLA2i 1.0 BCD110605C16 3.59 umol/ml of media
LMST01010017 Lanosterol cPLA2i 1.0 BCD110605C17 3.88 umol/ml of media
LMST01010017 Lanosterol cPLA2i 1.0 BCD110605C18 4.37 umol/ml of media
LMST01010017 Lanosterol cPLA2i 4.0 BCD110605C36 3.95 umol/ml of media
LMST01010017 Lanosterol cPLA2i 4.0 BCD110605C34 4.17 umol/ml of media
LMST01010017 Lanosterol cPLA2i 4.0 BCD110605C35 4.3 umol/ml of media
LMST01010017 Lanosterol cPLA2i 20.0 BCD110605C54 6.41 umol/ml of media
LMST01010017 Lanosterol cPLA2i 20.0 BCD110605C52 5.4 umol/ml of media
LMST01010017 Lanosterol cPLA2i 20.0 BCD110605C53 5.18 umol/ml of media
LMST01010017 Lanosterol PLDi 1.0 BCD110605C12 - umol/ml of media
LMST01010017 Lanosterol PLDi 1.0 BCD110605C10 4.14 umol/ml of media
LMST01010017 Lanosterol PLDi 1.0 BCD110605C11 4.14 umol/ml of media
LMST01010017 Lanosterol PLDi 4.0 BCD110605C30 4.3 umol/ml of media
LMST01010017 Lanosterol PLDi 4.0 BCD110605C29 4.5 umol/ml of media
LMST01010017 Lanosterol PLDi 4.0 BCD110605C28 4.24 umol/ml of media
LMST01010017 Lanosterol PLDi 20.0 BCD110605C46 5.79 umol/ml of media
LMST01010017 Lanosterol PLDi 20.0 BCD110605C48 7.12 umol/ml of media
LMST01010017 Lanosterol PLDi 20.0 BCD110605C47 7.89 umol/ml of media
LMST01010017 Lanosterol KDO+cPLA2i 1.0 BCD110605C21 4.24 umol/ml of media
LMST01010017 Lanosterol KDO+cPLA2i 1.0 BCD110605C20 3.72 umol/ml of media
LMST01010017 Lanosterol KDO+cPLA2i 1.0 BCD110605C19 4.11 umol/ml of media
LMST01010017 Lanosterol KDO+cPLA2i 4.0 BCD110605C39 4.63 umol/ml of media
LMST01010017 Lanosterol KDO+cPLA2i 4.0 BCD110605C37 5.05 umol/ml of media
LMST01010017 Lanosterol KDO+cPLA2i 4.0 BCD110605C38 4.43 umol/ml of media
LMST01010017 Lanosterol KDO+cPLA2i 20.0 BCD110605C55 9.84 umol/ml of media
LMST01010017 Lanosterol KDO+cPLA2i 20.0 BCD110605C57 7.21 umol/ml of media
LMST01010017 Lanosterol KDO+cPLA2i 20.0 BCD110605C56 5.63 umol/ml of media
LMST01010017 Lanosterol KDO+PLDi 1.0 BCD110605C14 3.79 umol/ml of media
LMST01010017 Lanosterol KDO+PLDi 1.0 BCD110605C13 4.37 umol/ml of media
LMST01010017 Lanosterol KDO+PLDi 1.0 BCD110605C15 3.98 umol/ml of media
LMST01010017 Lanosterol KDO+PLDi 4.0 BCD110605C31 4.21 umol/ml of media
LMST01010017 Lanosterol KDO+PLDi 4.0 BCD110605C33 3.17 umol/ml of media
LMST01010017 Lanosterol KDO+PLDi 4.0 BCD110605C32 4.08 umol/ml of media
LMST01010017 Lanosterol KDO+PLDi 20.0 BCD110605C50 6.05 umol/ml of media
LMST01010017 Lanosterol KDO+PLDi 20.0 BCD110605C51 8.51 umol/ml of media
LMST01010017 Lanosterol KDO+PLDi 20.0 BCD110605C49 7.47 umol/ml of media
LMST01010017 Lanosterol KDO + ATP 1.0 BCD110605C07 3.85 umol/ml of media
LMST01010017 Lanosterol KDO + ATP 1.0 BCD110605C09 4.5 umol/ml of media
LMST01010017 Lanosterol KDO + ATP 1.0 BCD110605C08 3.79 umol/ml of media
LMST01010017 Lanosterol KDO + ATP 4.0 BCD110605C25 4.34 umol/ml of media
LMST01010017 Lanosterol KDO + ATP 4.0 BCD110605C26 4.63 umol/ml of media
LMST01010017 Lanosterol KDO + ATP 4.0 BCD110605C27 4.76 umol/ml of media
LMST01010017 Lanosterol KDO + ATP 20.0 BCD110605C45 10.6 umol/ml of media
LMST01010017 Lanosterol KDO + ATP 20.0 BCD110605C43 8.31 umol/ml of media
LMST01010017 Lanosterol KDO + ATP 20.0 BCD110605C44 8.93 umol/ml of media
LMST01010017 Lanosterol C 0.0 BCD110605C02 4.14 umol/ml of media
LMST01010017 Lanosterol C 0.0 BCD110605C01 4.72 umol/ml of media
LMST01010017 Lanosterol C 0.0 BCD110605C03 - umol/ml of media
LMST01010017 Lanosterol C 1.0 BCD110605C06 3.85 umol/ml of media
LMST01010017 Lanosterol C 1.0 BCD110605C05 4.4 umol/ml of media